Your English writing platform
Discover LudwigExact(60)
Similarly, Nakasuka et al. [1] reported a case of UC of the liver with neuroendocrine features treated with the same regimen that resulted in a positive clinical course.
The patients with SMZL were previously treated on their anti-CD19 CAR-T cell protocol and obtained a PR lasting 12 weeks (Kochenderfer et al., 2012), then were retreated with the same regimen and obtained a PR with an ongoing response of 23 months as of the time of writing.
Patients who presented with a second (or further) episodes were treated with the same regimen as at enrolment.
Rats were administrated with 10 pmol (mPOA, N = 8; ARC, N = 7 for the ARC) or 50 pmol (mPOA, N = 8; ARC, N = 8) kisspeptin antagonist in 500 nl aCSF over the period of 5 min after 2 h of controlled blood sampling and then the same dosage was repeated on two further occasions at an interval of 30 min. Control animals received 500 nl aCSF only with the same regimen (mPOA, N = 7; ARC, N = 6).
Smith et al treated 42 patients with the same regimen.
Adjuvant chemotherapy with the same regimen was administered after 28 days after the end of radiotherapy.
The era of treating all patients with DLBCL with the same regimen is fading away.
Pharmacokinetics were further investigated in 12 OA patients with the same regimen of administration [ 47].
Mice were boosted with the same regimen on day 10 and 17 after tumor inoculation.
Response rates to retreatment with the same regimen ranged from 18 to 100%.
Two have since relapsed, and one responded to re-challenge with the same regimen.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com